pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 30·1 min read
save

Anthropic to launch its own drug-development program using Claude Science AI

Jun 30, 2026·read at STAT ↗Positive

Anthropic, an AI company best known for its Claude models, announced it will begin developing its own drug candidates.

Executives said the effort is meant to give the firm hands-on experience applying its Claude Science platform to real scientific challenges, though they did not detail any plans to bring products to market.

The move highlights Anthropic's shift from pure model training toward life-science applications, underscoring the growing interest of AI firms in drug discovery.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: AI company Anthropic announces it will begin developing drugs of its own”

read at STAT ↗
484 words · retrieved Jul 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Gene Therapy (AAV)

related stories

  • May 4UCB to acquire maker of antibody treatments for autoimmune diseasesSTAT
  • May 4STAT+: Biotech raises $42 million to run Huntington’s disease trialSTAT
  • Apr 30STAT+: Katherine Szarama named acting director of FDA’s vaccines and biologics centerSTAT
  • Apr 30UniQure, in ‘symbolic’ win, to seek UK approval of Huntington’s gene therapyBioPharma Dive
  • Apr 30STAT+: Five-way obesity drug is super effective — in miceSTAT